{{Rsnum
|rsid=6850606
|Chromosome=4
|position=42862679
|Orientation=plus
|GMAF=0.421
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 55.8 | 19.5
| HCB | 6.6 | 42.3 | 51.1
| JPT | 8.0 | 37.5 | 54.5
| YRI | 16.3 | 49.0 | 34.7
| ASW | 10.5 | 47.4 | 42.1
| CHB | 6.6 | 42.3 | 51.1
| CHD | 8.3 | 44.0 | 47.7
| GIH | 17.8 | 51.5 | 30.7
| LWK | 17.3 | 46.4 | 36.4
| MEX | 17.2 | 43.1 | 39.7
| MKK | 25.0 | 54.5 | 20.5
| TSI | 24.5 | 54.9 | 20.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23055271
  |Trait=Myasthenia gravis
  |Title=Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
  |RiskAllele=A
  |Pval=3E-6
  |OR=1.35
  |ORtxt=[1.19-1.53]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}